These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 5202486)

  • 21. [Synovial fluid and the importance of its examination in the diagnosis of joint diseases].
    Duliapin VA
    Vopr Revm; 1974; (4):72-7. PubMed ID: 4141172
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical chemistry in equine practice. Examination of synovial and peritoneal fluids.
    Coffman JF
    Mod Vet Pract; 1974 Dec; 55(12):957, 959-60. PubMed ID: 4431401
    [No Abstract]   [Full Text] [Related]  

  • 23. Onset and duration of corticosteroid effect after injection of Betasone for treating equine arthropathies. Results of laboratory and clinical studies.
    Vernimb GD; Van Hoose LM; Hennessey PW
    Vet Med Small Anim Clin; 1977 Feb; 72(2):241-4. PubMed ID: 584596
    [No Abstract]   [Full Text] [Related]  

  • 24. Field trials of a new long-acting corticosteroid in the treatment of equine arthropathies.
    Houdeshell JW
    Vet Med Small Anim Clin; 1969 Sep; 64(9):782-4. PubMed ID: 5194681
    [No Abstract]   [Full Text] [Related]  

  • 25. [Inflammatory joint effusion. A diagnositic and therapeutic problem].
    Müller W
    Med Klin; 1979 May; 74(21):789-801. PubMed ID: 381877
    [No Abstract]   [Full Text] [Related]  

  • 26. Injections for joint and soft tissue disorders: when and how to use them.
    Zuckerman JD; Meislin RJ; Rothberg M
    Geriatrics; 1990 Apr; 45(4):45-52, 55. PubMed ID: 2180787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The molecular weight of therapeutic hyaluronan (sodium hyaluronate): how significant is it?
    Aviad AD; Houpt JB
    J Rheumatol; 1994 Feb; 21(2):297-301. PubMed ID: 8182640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of infrared absorption spectral characteristics of synovial fluid of horses with osteochondrosis of the tarsocrural joint.
    Vijarnsorn M; Riley CB; Ryan DA; Rose PL; Shaw RA
    Am J Vet Res; 2007 May; 68(5):517-23. PubMed ID: 17472451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of glycosaminoglycan concentration in equine synovial fluid as a marker of joint disease.
    Palmer JL; Bertone AL; McClain H
    Can J Vet Res; 1995 Jul; 59(3):205-12. PubMed ID: 8521354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral rosmarinic acid-enhanced Mentha spicata modulates synovial fluid biomarkers of inflammation in horses challenged with intra-articular LPS.
    Pearson W; Fletcher RS; Kott LS
    J Vet Pharmacol Ther; 2012 Oct; 35(5):495-502. PubMed ID: 22070392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of MMP-2 and -9 activities in synovial fluid of horses with osteoarthritic and arthritic joint diseases using gelatin zymography and immunocapture activity assays.
    Fietz S; Einspanier R; Hoppner S; Hertsch B; Bondzio A
    Equine Vet J; 2008 May; 40(3):266-71. PubMed ID: 18089467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of alkaline phosphatase in vitro on the relative viscosity and mucinous precipitate quality of bovine synovial fluid.
    Van Pelt RW
    Am J Vet Res; 1971 Dec; 32(12):1937-43. PubMed ID: 5131420
    [No Abstract]   [Full Text] [Related]  

  • 33. Measurement of equine myeloperoxidase (MPO) activity in synovial fluid by a modified MPO assay and evaluation of joint diseases - an initial case study.
    Fietz S; Bondzio A; Moschos A; Hertsch B; Einspanier R
    Res Vet Sci; 2008 Jun; 84(3):347-53. PubMed ID: 17675122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammation of the tarsal synovial sheath (thoroughpin) in horses.
    Van Pelt RW
    J Am Vet Med Assoc; 1969 Nov; 155(9):1481-8. PubMed ID: 5394643
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of the effect of polysulfated glycosaminoglycan, corticosteroids, and sodium hyaluronate in the potentiation of a subinfective dose of Staphylococcus aureus in the midcarpal joint of horses.
    Gustafson SB; McIlwraith CW; Jones RL
    Am J Vet Res; 1989 Dec; 50(12):2014-7. PubMed ID: 2610426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteochondral fragments involving the dorsomedial aspect of the proximal interphalangeal joint in young horses: 6 cases (1997-2006).
    Fjordbakk CT; Strand E; Milde AK; Ihler CF; Rorvik AM
    J Am Vet Med Assoc; 2007 May; 230(10):1498-501. PubMed ID: 17504041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synovial fluid.
    Coffman J
    Vet Med Small Anim Clin; 1980 Sep; 75(9):1403-6. PubMed ID: 6904116
    [No Abstract]   [Full Text] [Related]  

  • 38. Cefotaxime kinetics in plasma and synovial fluid following intravenous administration in horses.
    Orsini JA; Moate PJ; Engiles J; Norman T; Poppenga R; Benson CE; Boston RC
    J Vet Pharmacol Ther; 2004 Oct; 27(5):293-8. PubMed ID: 15500566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental model of synovitis/capsulitis in the equine metacarpophalangeal joint.
    Cornelissen BP; Rijkenhuizen AB; van den Hoogen BM; Rutten VP; Barneveld A
    Am J Vet Res; 1998 Aug; 59(8):978-85. PubMed ID: 9706201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma and synovial fluid endothelin-1 and nitric oxide concentrations in horses with and without joint disease.
    de la Calle J; Burba DJ; Ramaswamy CM; Hosgood G; Williams J; LeBlanc C; Moore RM
    Am J Vet Res; 2002 Dec; 63(12):1648-54. PubMed ID: 12492278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.